Insider Transactions in Q4 2022 at Pasithea Therapeutics Corp. (KTTA)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 28
2022
|
Lawrence Steinman Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+0.39%
|
$0
$0.98 P/Share
|
|
Nov 25
2022
|
Tiago Marques Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+0.24%
|
$2,000
$1.03 P/Share
|
|
Nov 23
2022
|
Tiago Marques Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,206
+0.29%
|
$7,206
$1.02 P/Share
|
|
Nov 22
2022
|
Lawrence Steinman Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+0.39%
|
$0
$0.99 P/Share
|
|
Nov 17
2022
|
Simon Dumesnil Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+44.44%
|
$40,000
$1.06 P/Share
|
|
Nov 15
2022
|
Simon Dumesnil Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+50.0%
|
$10,000
$1.07 P/Share
|
|
Oct 26
2022
|
Lawrence Steinman Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+0.39%
|
$5,000
$1.1 P/Share
|
|
Oct 21
2022
|
Tiago Marques Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+0.31%
|
$5,000
$1.08 P/Share
|
|
Oct 17
2022
|
David Delaney |
BUY
Open market or private purchase
|
Indirect |
1,000
+0.44%
|
$1,000
$1.11 P/Share
|
|
Oct 17
2022
|
Lawrence Steinman Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+0.39%
|
$10,000
$1.14 P/Share
|